Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic

• Asıl Yazarlar: Serena Romani (Yazar), Alexandre Gérard (Yazar), Audrey Fresse (Yazar), Delphine Viard (Yazar), Élise Van‐Obberghen (Yazar), Joëlle Micallef (Yazar), Fanny Rocher (Yazar), Milou‐Daniel Drici (Yazar), the French Pharmacovigilance Network (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The recent empirical use of hydroxychloroquine (HCQ) in coronavirus disease 2019 (COVID‐19) revived the interest in its cardiac toxicity, increasingly sidelined over time. We aimed to assess and compare the profile of cardiac adverse drug reactions (CADRs) associated with HCQ before and during COVID...